semaglutide patent expiration date Novo's Ozempic Expires Jan. 4 in Canada, But Generics Not Imminent Why Delhi HC rejected semaglutide

Mazdutide and Retatrutide represents two of the most fascinating new peptides in modern obesity pharmacotherapy

Novo Nordisks semaglutide will soon be available in a daily pill Americans can take for weight loss.

Combining spironolactone with GLP-1 medications like semaglutide requires careful medical oversight due to potential effects on kidney function and electrolyte balance

D-Allulose, a generally regarded as safe (GRAS) sugar, is rare in nature

Join our Physician-Directed GLP-1 Weight Management Clinic

Carmot acquisition propels Roche to forefront of obesity drug leadership, finds GlobalData In a significant move in December 2023, Roche completed the acquisition of the US-based company Carmot Therapeutics in a deal worth $2.9 billion